David P Schenkein - Net Worth and Insider Trading
David P Schenkein Net Worth
The estimated net worth of David P Schenkein is at least $24 Million dollars as of 2024-06-05. David P Schenkein is the Director of Agios Pharmaceuticals Inc and owns about 472,708 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $22 Million. David P Schenkein is the Director of Denali Therapeutics Inc and owns about 57,464 shares of Denali Therapeutics Inc (DNLI) stock worth over $1 Million. David P Schenkein is also the Director of bluebird bio Inc and owns about 3,176 shares of bluebird bio Inc (BLUE) stock worth over $3,076. Details can be seen in David P Schenkein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David P Schenkein has not made any transactions after 2024-02-27 and currently still holds the listed stock(s).
Transaction Summary of David P Schenkein
David P Schenkein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David P Schenkein owns 6 companies in total, including bluebird bio Inc (BLUE) , Denali Therapeutics Inc (DNLI) , and Agios Pharmaceuticals Inc (AGIO) among others .
Click here to see the complete history of David P Schenkein’s form 4 insider trades.
Insider Ownership Summary of David P Schenkein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BLUE | bluebird bio Inc | 2017-08-31 | director |
DNLI | Denali Therapeutics Inc | 2020-12-21 | director |
AGIO | Agios Pharmaceuticals Inc | 2024-02-27 | director & 10 percent owner & Chief Executive Officer |
2016-06-16 | director | ||
2022-10-19 | director | ||
2023-09-08 | director |
David P Schenkein Latest Holdings Summary
David P Schenkein currently owns a total of 3 stocks. Among these stocks, David P Schenkein owns 472,708 shares of Agios Pharmaceuticals Inc (AGIO) as of February 27, 2024, with a value of $22 Million and a weighting of 94.95%. David P Schenkein owns 57,464 shares of Denali Therapeutics Inc (DNLI) as of December 21, 2020, with a value of $1 Million and a weighting of 5.04%. David P Schenkein also owns 3,176 shares of bluebird bio Inc (BLUE) as of August 31, 2017, with a value of $3,076 and a weighting of 0.01%.
Latest Holdings of David P Schenkein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AGIO | Agios Pharmaceuticals Inc | 2024-02-27 | 472,708 | 47.35 | 22,382,724 |
DNLI | Denali Therapeutics Inc | 2020-12-21 | 57,464 | 20.67 | 1,187,781 |
BLUE | bluebird bio Inc | 2017-08-31 | 3,176 | 0.97 | 3,076 |
Holding Weightings of David P Schenkein
David P Schenkein Form 4 Trading Tracker
According to the SEC Form 4 filings, David P Schenkein has made a total of 9 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years, including 1 buys and 8 sells. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 69,329 shares on February 27, 2024, which brought David P Schenkein around $2 Million.
According to the SEC Form 4 filings, David P Schenkein has made a total of 4 transactions in Denali Therapeutics Inc (DNLI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Denali Therapeutics Inc is the sale of 30,000 shares on December 21, 2020, which brought David P Schenkein around $3 Million.
According to the SEC Form 4 filings, David P Schenkein has made a total of 0 transactions in bluebird bio Inc (BLUE) over the past 5 years. The most-recent trade in bluebird bio Inc is the sale of 2,000 shares on August 31, 2017, which brought David P Schenkein around $230,140.
Insider Trading History of David P Schenkein
- 1
David P Schenkein Trading Performance
GuruFocus tracks the stock performance after each of David P Schenkein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David P Schenkein is 51.54%. GuruFocus also compares David P Schenkein's trading performance to market benchmark return within the same time period. The performance of stocks bought by David P Schenkein within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David P Schenkein's insider trading performs compared to the benchmark.
Performance of David P Schenkein
David P Schenkein Ownership Network
Ownership Network List of David P Schenkein
Ownership Network Relation of David P Schenkein
David P Schenkein Owned Company Details
What does bluebird bio Inc do?
Who are the key executives at bluebird bio Inc?
David P Schenkein is the director of bluebird bio Inc. Other key executives at bluebird bio Inc include Chief Commercial Officer & SGD Thomas J Klima , President of SGD Andrew Obenshain , and Chief Medical Officer Richard A Colvin .
bluebird bio Inc (BLUE) Insider Trades Summary
Over the past 18 months, David P Schenkein made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 32,050 shares made by Andrew Obenshain , a net sale of 16,173 shares made by Thomas J Klima , and a net sale of 10,267 shares made by Richard A Colvin .
In summary, during the past 3 months, insiders sold 3,834 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 3,834 shares. During the past 18 months, 72,523 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 72,523 shares.
bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
bluebird bio Inc Insider Transactions
David P Schenkein Mailing Address
Above is the net worth, insider trading, and ownership report for David P Schenkein. You might contact David P Schenkein via mailing address: C/o Bluebird Bio, Inc., 840 Memorial Drive, Cambridge Ma 02139.